Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models
Engin E, Treit D, Dickson CT.
Department of Psychology,
University of Alberta,
Edmonton, AB, Canada T6G 2E9.
Neuroscience. 2009 Mar 22.
ABSTRACTKetamine, a dissociative anesthetic agent, appears to have rapid antidepressant effects at sub-anesthetic doses in clinically depressed patients. Although promising, these results need to be replicated in double-blind placebo controlled studies, a strategy thwarted by the psychoactive effects of ketamine, which are obvious to both patients and clinicians. Alternatively, demonstrations of the psychotherapeutic effects of ketamine in animal models are also complicated by ketamine's side-effects on general activity, which have not been routinely measured or taken into account in experimental studies. In this study we found that ketamine decreased "behavioral despair" in the forced swim test, a widely used model of antidepressant drug action. This effect was not confounded by side-effects on general activity, and was comparable to that of a standard antidepressant drug, fluoxetine. Interestingly, ketamine also produced anxiolytic-like effects in the elevated-plus-maze. Importantly, the effective dose of ketamine in the plus-maze did not affect general locomotion measures, in either the plus-maze or in the open field test. While the selective NMDA receptor antagonist MK-801 also produced antidepressant-like and anxiolytic-like effects, these were mostly confounded by changes in general activity. Finally, in a neurophysiological model of anxiolytic drug action, ketamine reduced the frequency of reticularly-activated theta oscillations in the hippocampus, similar to the proven anxiolytic drug diazepam. This particular neurophysiological signature is common to all known classes of anxiolytic drugs (i.e., benzodiazepines, 5-HT1A agonists, antidepressants) and provides strong converging evidence for the anxiolytic-like effects of ketamine. Further studies are needed to understand the underlying pharmacological mechanisms of ketamine's effects in these experiments, since it is not clear they were mimicked by the selective NMDA antagonist MK-801.
Ketamine and memory
Ketamine and cognition
Comfortably numb? (PDF)
Anaesthesia and anaesthetics
Ketamine as an antidepressant
Ketamine and opiate withdrawal
Ketamine and the nucleus accumbens
Ketamine: medical and non-medical use
The role of ketamine in pain management
Glutamate modulators to treat mood disorders?
Ketamine is not a long-acting antidepressant for rats
Ketamine racemate versus S-(+)-ketamine and midazolam
Ketamine and the glutaminergic hypothesis of schizophrenia
Biomarker predicts rapid antidepressant response to ketamine
Low-dose ketamine as a fast-onset, long-acting antidepressant
and further reading
The Abolitionist Project
The Hedonistic Imperative
MDMA: Utopian Pharmacology
Dissociative Anaesthetics: Ketamine
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family